As an expert in the field of brain-computer interfaces (BCI) and neurotechnology, Ivan Kairatov has
The prevailing wisdom that all physical activity is created equal has faced a significant challenge
The most formidable barrier to treating aggressive brain cancer may not be the physical skull or the blood-brain barrier, but the cellular invisibility cloak that allows these tumors to ignore the body’s natural defenses. For decades, the primary strategy in oncology has been to train the immune
The sudden occlusion of a coronary artery initiates a catastrophic sequence of cellular death that fundamentally alters the architectural integrity of the human heart within minutes. While contemporary emergency medicine has become remarkably efficient at reestablishing blood flow through
The landscape of childhood has undergone a silent but profound transformation as digital interfaces
The traditional healthcare model has long functioned as a reactive cleanup crew that only arrives
The biopharmaceutical sector is entering a new era. After last year's market disruptions, the industry faces a harsh truth: scientific breakthroughs alone are no longer enough to keep ahead of the…
The End of the Old Biopharma Playbook The biopharmaceutical industry is confronting a structural
By 2030, the tissue-engineering market is projected to exceed $32.45 billion , reflecting a
The landscape of rare disease drug development is littered with clinical failures. For every
Major policy changes are colliding with the complex economics of drug development. For B2B
The integration of artificial intelligence into the complex fabric of modern medical infrastructure has moved far beyond the realm of theoretical research to become a primary driver of clinical decision support. However, this rapid evolution has encountered a formidable bottleneck known as the
The genetic landscape of common epilepsies has long been a subject of intense investigation, yet
As an expert in the field of brain-computer interfaces (BCI) and neurotechnology, Ivan Kairatov has
